NEW YORK, NY — As Breast Cancer Awareness Month unfolds across the globe, the pervasive pink imagery of early detection campaigns often dominates the public consciousness. Yet, for a significant and often overlooked community, the narrative is starkly different. On October 13, National Metastatic Breast Cancer Awareness Day, a global movement is set to shift the focus from prevention to the urgent, life-saving need for research into Stage 4 disease.
Through the #LightUpMBC campaign, more than 325 landmarks spanning 50 U.S. states, 20 countries, and 195 cities will bathe in teal, green, and pink—the symbolic colors of metastatic breast cancer (MBC) awareness. This synchronized display serves as a poignant reminder that while many celebrate the "war on cancer," those living with the terminal, incurable reality of Stage 4 disease are fighting for every day they have left.
The Reality of Stage 4: What is Metastatic Breast Cancer?
Metastatic breast cancer occurs when cancer cells migrate from the original site in the breast to distant organs, most commonly the bones, liver, lungs, or brain. It is vital to clarify a common misconception: even when found in the lungs or liver, it is not "lung cancer" or "liver cancer"; it remains breast cancer, now spread.
For some, the diagnosis is "de novo," meaning it is Stage 4 from the very first scan. For others, the disease returns months, years, or even decades after initial treatment for earlier-stage cancer. In either scenario, the reality is the same: the disease is incurable.
"Treatment is a continuous, lifelong process," says Dr. Kelly Shanahan, Board President of METAvivor and a patient living with MBC since 2013. "Even when scans show no evidence of disease, that does not mean the cancer has been cured. We are in a state of permanent management, constantly waiting for the next scan, the next therapy change, and the next challenge to our quality of life."
The goal for patients is not a "cure," as that is currently medically impossible for this stage of the disease. Instead, the focus is on "chronic management"—extending life and maintaining the highest possible quality of life while navigating the inevitable resistance cancer develops to various treatment modalities.
Chronology of a Movement: From One Landmark to a Global Phenomenon
The origins of #LightUpMBC are deeply personal, rooted in the grief and resolve of a best friend’s promise. Laura Inahara, the founder of the campaign, launched the initiative in honor of Jessica Moore, who tragically succumbed to metastatic breast cancer at the age of 36.
The Timeline of Impact:
- 2017: The movement began with a single, humble ambition: to illuminate one local landmark in honor of Jessica Moore. The Portsmouth Memorial Bridge in New Hampshire became the inaugural site, marking the first time a landmark glowed in the colors of MBC awareness.
- 2018–2024: The campaign gained momentum, growing from a local act of remembrance to a national and eventually international phenomenon. Each year, the number of participating cities grew as patient advocates realized the power of visual solidarity.
- 2026 (Present Day): The initiative now spans over 325 locations globally, including iconic sites like New York’s One World Trade Center, the Willis Tower in Chicago, Niagara Falls, and the Ness Bridge in Scotland.
What began as a personal tribute has blossomed into a logistical marvel, raising over $2.7 million for critical research. The movement proves that collective action, when driven by personal stakes, can force a neglected topic into the global spotlight.
Supporting Data: The Urgent Need for Investment
The necessity of this campaign is underscored by sobering statistics. In the United States alone, an estimated 42,670 people are expected to lose their lives to breast cancer in 2026. This translates to roughly 117 deaths every single day.
Despite these high mortality rates, research funding for metastatic breast cancer remains disproportionately low compared to early-stage screening and prevention. METAvivor Research and Support, the primary beneficiary of the #LightUpMBC campaign, has made it their mission to bridge this gap.
Unlike many organizations that allocate funds to a broad spectrum of cancer research, METAvivor operates with a singular, laser-focused mandate: to fund Stage 4 research exclusively. Their methodology involves a rigorous scientific peer and patient advocate review process, ensuring that every dollar raised goes toward projects with the highest potential to transform MBC from a terminal, death-sentence condition into a manageable, chronic disease.
Official Voices: The Faces Behind the Lights
The #LightUpMBC Live event, scheduled for October 13 at 8:00 p.m. ET (5:00 p.m. PT), serves as the heartbeat of the campaign. Hosted by Tami Eagle Bowling—who has lived with MBC for 11 years—and Broadway performer and breast cancer survivor Kara Lindsay, the stream promises a blend of advocacy, education, and art.
"My hope and the hope of so many others lies in research," says Dr. Shanahan. "METAvivor-funded research is increasingly important because we are seeing more therapies that can keep patients alive longer than we ever thought possible a decade ago. #LightUpMBC is the biggest contributor to this, but more than that, it is the glue that holds our community together."
The program is designed to humanize the statistics. By sharing patient stories live from illuminated landmarks, the organizers hope to break the isolation that often accompanies a Stage 4 diagnosis. The event will also feature musical performances by Victoria Clark, Dorian Harewood, Christina Bianco, Cassandra Kubinski, and Tony Daniels, providing a platform for healing through the arts.
Implications for the Future: Why Awareness Must Lead to Action
The fundamental implication of the #LightUpMBC campaign is a call for a shift in the cultural narrative surrounding breast cancer. The "pink ribbon" culture has been highly successful in promoting mammograms and early-stage awareness, but it has inadvertently created a "survivor" narrative that leaves those with metastatic disease feeling invisible or alienated.
By insisting on the colors teal, green, and pink, METAvivor is reclaiming the narrative. They are asserting that patients who don’t "survive" in the traditional sense still matter, and that their lives deserve the same level of scientific investment and public empathy as those caught in the early stages.
The Path Forward:
- Direct Funding: By channeling 100% of net proceeds from the campaign directly into research grants, the movement is actively accelerating the discovery of new drug therapies and clinical trial opportunities.
- Patient Advocacy Training: The campaign provides resources for patients to learn how to advocate for their own care, empowering them to participate in clinical decision-making.
- Policy Shifts: By bringing awareness to major landmarks, the campaign forces local and national governments to acknowledge the prevalence of the disease, potentially opening doors for greater legislative support and federal funding.
As the sun sets on October 13, the world will see a different kind of illumination. It will not be a celebration of "beating" the disease, but a solemn and hopeful display of solidarity for those living through it.
"Jessica hoped to illuminate one local landmark," says founder Laura Inahara. "Today, her legacy helps families around the world shine a light for the people they love. It is about teaching patients to advocate for themselves and proving that even in the darkest of times, we can create a beacon of hope that is visible to everyone."
The public is encouraged to join the movement by visiting www.lightupmbc.org to view the map of participating landmarks, find streaming links for the live broadcast, or make a contribution. By tagging @LightUpMBC and using #LightUpMBC and #METAvivor on social media, supporters can ensure that the conversation around metastatic breast cancer continues long after the lights fade.
About the Author
